Company intelligence / Profile preview
Teleost Biopharmaceuticals
Tucson, Arizona, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Teleost Biopharmaceuticals has developed patented synthetic peptides that stimulate melanin production without UV exposure; their main application is skin protection and tanning, with partnered development for oral melanocortin peptides targeting weight loss and eating disorders. Most programs are at the pre-clinical or early research stage.
- Therapeutic areas
- EndocrinologyMetabolic DisordersPsychiatryDermatologyOncology
- Modalities
- PeptidesSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ANEW MedicalUniversity of Arizona
Beyond the preview
Go deeper on Teleost Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Teleost Biopharmaceuticals.